Nirsevimab (MEDI8897) is a recombinant monoclonal antibody designed to target and neutralize human respiratory syncytial virus (RSV). This antibody exhibits potent neutralizing activity against both RSV A and RSV B strains, demonstrated by IC50 values of 5.42 ng/mL and 9.71 ng/mL, respectively. Nirsevimab is an essential tool for research focused on respiratory infections caused by RSV, facilitating the study of virus-host interactions and the evaluation of preventive therapies.
Nirsevimab (MEDI8897) is a recombinant monoclonal antibody designed to target and neutralize human respiratory syncytial virus (RSV). This antibody exhibits potent neutralizing activity against both RSV A and RSV B strains, demonstrated by IC50 values of 5.42 ng/mL and 9.71 ng/mL, respectively. Nirsevimab is an essential tool for research focused on respiratory infections caused by RSV, facilitating the study of virus-host interactions and the evaluation of preventive therapies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
